Reporting for the Merit-based Incentive Payment System (MIPS) is particularly vulnerable to fraud, OIG said, because it relies on clinicians on submitting their own data—and allows them to resubmit data to change their score.

Racial discrimination was by far the most common reason cited by black patients for receiving poor service or treatment from physicians or hospitals, according to a study published in the Journal of General Internal Medicine. White and Hispanic patients, however, also reported “high rates of discrimination” for other reasons such as age, weight or income.

Israel-based Teva Pharmaceuticals, the largest generic drugmaker in the world, will be laying off 14,000 employees, a quarter of its workforce worldwide, including “significant” cuts to its 7,000 U.S. workers.

CMS’s move to cut Medicare payments made through the 340B drug discount programs would see the biggest impact in California, New York and North Carolina, according to an analysis by Avalere Health, though for most hospitals it will reduce their total Part B revenue by less than 5 percent.

Providers represented by the American Medical Group Association (AMGA) expect more of their business to come from risk-based products in 2019, with government revenues moving from Medicare fee-for-service (FFS) towards Medicare Advantage and shared risk accounting for a greater share of revenue in commercial settings.